4//SEC Filing
Moxie Dwight 4
Accession 0001479290-23-000040
CIK 0001479290other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 3:21 PM ET
Size
5.0 KB
Accession
0001479290-23-000040
Insider Transaction Report
Form 4
Moxie Dwight
CLO & GC
Transactions
- Tax Payment
Common Stock
2023-03-15$30.65/sh−7,330$224,665→ 48,217 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock awards (the"RSA") totaling 14,783 shares. 8,334 of the shares were issued pursuant to a RSA vested in three equal annual installments from March 15, 2020, and the remaining 6,449 shares were issued pursuant to a RSA that vests in three equal annual installments from March 15, 2021.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001803375
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 3:21 PM ET
- Size
- 5.0 KB